Developer docs
API playgroundTry for free, no card

Search company profiles

Soundbites

Full company profile

uuid003d6qx

Namestring
Soundbites
Legal namestring
Soundbites Public Benefit Corporation
Websiteurl
soundbites.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Soundbites Public Benefit Corporation is a Delaware-incorporated hearing health company that commercializes a patented micronutrient formulation called ACEMg (provitamin A/beta-carotene, vitamins C and E, and magnesium) as a once-daily dietary supplement marketed under the Soundbites brand. The product targets adults with sensorineural hearing loss who fall in the clinical gap between diagnosis and hearing-aid candidacy, as well as individuals seeking protection from noise-induced or age-related hearing decline. The core offering is sold direct-to-consumer through shop.soundbites.com at $39.99 per 4-week supply (one-time) or $33.99 on a cancellable 4-week subscription, with a 12-week starter kit priced at $80. A parallel wholesale channel serves licensed audiologists, primary care physicians, and otolaryngologists for in-office dispensing.

The technology base is anchored by 11 issued U.S. patents (two held directly by Soundbites PBC and nine exclusively licensed from the University of Michigan Kresge Hearing Research Institute) and 26 peer-reviewed publications documenting the formulation's mechanism of action in reducing cochlear oxidative stress. Manufacturing uses RP Scherer softgel technology in an FDA-certified pharmaceutical facility. Two adjacent software products extend the portfolio: Soundware, a validated at-home speech-in-noise and tone hearing assessment platform for longitudinal self-monitoring, and Otis, an RAG-based generative AI chatbot that fields consumer questions about hearing health. The company ships to the United States (free shipping), Canada, Hong Kong, the United Kingdom, the Netherlands, and China.

Soundbites operates as a Public Benefit Corporation with 1-10 employees, headquartered at 2370 East Stadium Blvd, Ann Arbor, Michigan, with a secondary office in Windsor, Canada. The company was incorporated in 2017 by Barry Seifer (CEO) following the passing of co-founder Dr. Josef M. Miller, the University of Michigan auditory neuroscientist whose 38-year research program generated the ACEMg technology and underlying patents. Capital formation has come from academic and governmental grants — approximately $22 million in NIH/NIDCD funding (1988-2017) and a €5 million European Commission medical innovation grant (2012) — rather than venture capital. Distribution combines a consumer e-commerce front end with a clinician wholesale tier and content marketing through the company Journal, press relations, and clinician education resources.

Short descriptiontext

Soundbites Public Benefit Corporation sells a patented ACEMg dietary supplement for hearing preservation, serving adults with sensorineural hearing loss and noise-exposed individuals through direct-to-consumer e-commerce and clinician wholesale channels, complemented by the Soundware assessment platform and Otis AI chatbot.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hearing preservation supplements, auditory micronutrition, noise-induced hearing loss, cochlear oxidative stress, sensorineural hearing support
Industry2 codes
PRIMARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYEDAFAKAC
Assistive Hearing & Communication Access (Captioning, Hearing Support, Transcription)
Education/Education Technology (EdTech) & Digital Learning/Accessibility, Assistive Technology & Special Needs EdTech
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Hearing Health Dietary Supplements
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct Product Sales
TypeSubscription Recurring
Description

Sale of ACEMg supplement (Soundbites) directly to consumers via e-commerce platform. One-time purchases and subscription plans for individual consumers seeking hearing preservation supplements.

soundbites.com
2Wholesale/Professional Sales
TypeSubscription Recurring
Description

Wholesale pricing offered to licensed healthcare practitioners (audiologists, physicians) for in-office dispensing. Includes volume pricing and access to clinical support resources.

soundbites.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1One-time purchase - $39.99 per bottle
ModelSubscriptionBilling cadencePay-as-you-go
Notes

One-time purchase: $39.99 per bottle (4-week supply, 56 softgels). Two capsules daily.

soundbites.com
2Subscription - $33.99 per 4-week cycle
ModelSubscriptionBilling cadenceMonthly
Notes

Subscription: $33.99 every 4 weeks (cancel anytime). Includes free U.S. shipping.

soundbites.com
312-Week Starter Kit - $80 (save $40)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

New customer offer: 12-Week Starter Kit at $80 (3 bottles), saving $40 compared to regular pricing. Includes free U.S. shipping.

soundbites.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Otis
Description

AI-powered hearing health chatbot (otology information system) designed to answer hearing questions and provide information about Soundbites and hearing preservation

soundbites.com
+1 more record
Core offering1 text field

Soundbites sells a patented daily dietary supplement (ACEMg softgel) that delivers a specific combination of provitamin A/beta-carotene, vitamin C, vitamin E, and magnesium in patented ratios to support inner ear antioxidant defenses and preserve auditory function. The supplement is offered directly to consumers via the company's e-commerce store as one-time purchases or 4-week subscriptions, and through wholesale clinician channels for in-office dispensing by audiologists and physicians. The company also operates Soundware (a free at-home hearing assessment platform) and Otis (an AI chatbot) to support product adoption and hearing health education.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 75.3% of daily ACEMg users maintained or improved DPOAE scores over two years, compared to 26.8% in untreated controls
+3 more records
Product overview1 text field

Soundbites Public Benefit Corporation (PBC) offers a portfolio of hearing health products built around the patented ACEMg (Antioxidant vitamins C and E, and Magnesium) formulation. The core offering is the Soundbites dietary supplement (softgel capsules), which is paired with Soundware — a free at-home hearing assessment platform (speech-in-noise and tone tests) — enabling users to monitor and measure the supplement's impact on their hearing. An AI chatbot called Otis, powered by RAG and generative models, provides hearing health information to website visitors. The portfolio is grounded in 38 years of peer-reviewed research from the University of Michigan Kresge Hearing Research Institute.

Product and service2 records
1Soundbites (ACEMg) Daily Hearing Preservation Supplement
CategoryDietary Supplement
Description

A daily dietary supplement in softgel capsule form containing the patented ACEMg formula (provitamin A/beta-carotene, vitamin C, vitamin E, and magnesium). Manufactured in an FDA-certified pharmaceutical facility using RP Scherer softgel technology. Sold to adults with diagnosed sensorineural hearing loss or seeking hearing preservation, and dispensed in-office by licensed clinicians.

2Soundware Hearing Assessment Platform
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

38-year research partnership with Dr. Josef M. Miller at the University of Michigan Medical School Kresge Hearing Research Institute. This partnership developed the foundational ACEMg technology, including 9 patents exclusively licensed to Soundbites PBC. Research supported by NIH/NIDCD grants totaling approximately $22 million over 29 years.

2Keep Hearing Initiative
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated 501(c)(3) nonprofit organization that supports research, education, and global access to hearing preservation. Contributed to Soundbites PBC's research and education projects since 2019, producing educational videos, co-authoring the real-world evidence study, and collaborating on Soundware development. Pursues global access to ACEMg independent of ability to pay.

soundbites.com
Strategic tierSignificantTypeStrategic or Co-development Partner
Description

Private audiology clinic in Lake Forest, Illinois that served as the clinical site for the real-world evidence study. Records were extracted from the clinic's electronic medical records and deidentified by licensed audiologist L.A. Halvorson before analysis.

4ProHearing Consortium
Strategic tierSignificantTypeStrategic or Co-development Partner
Description

European Commission-funded consortium of three universities and Hearing Health Science, Inc. (University of Michigan patent licensee) for translational research on ACEMg from 2012-2020.

soundbites.com
Strategic tierSupportingTypeTechnology or Integration
Description

R&D partner contributing to Soundware hearing assessment platform development.

Strategic tierSupportingTypeTechnology or Integration
Description

R&D partner listed on website footer alongside other research partners.

Strategic tierActiveTypeStrategic or Co-development Partner
Description

Clinical study titled 'ACEMg for Hearing Preservation and Tinnitus Relief' registered at clinicaltrials.gov (NCT06477354) evaluating ACEMg's impact on hearing preservation and tinnitus outcomes using AirPods hearing test data from participants.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Audicus
TypeBroad incumbent
Description

Online hearing-aid retailer serving adults with mild-to-moderate hearing loss via subscription/financing models. Comparable DTC hearing-health customer and GTM motion, but in amplification rather than supplements.

2Care/of
TypeBroad incumbent
Description

Personalized DTC vitamin/supplement brand with subscription model, transparent quality sourcing, and direct e-commerce — analogous business model and DTC mechanics for a subscription-driven health product like ACEMg.

TypeEmerging player
Description

Clinical-stage company developing regenerative therapies for hearing loss (e.g., FX-322). Direct strategic reference for the drug-development trajectory that Soundbites could ultimately pursue if human trials and IP mature.

TypeBroad incumbent
Description

Premium, science-led DTC supplement brand with practitioner-channel distribution and NSF/clinical quality positioning. Highly comparable business model, brand posture, and clinician channel strategy to Soundbites' ACEMg offering.

TypeDirect peer
Description

Swiss-based OTC brand selling homeopathic ear-care products (e.g., Ear Relief Drops) through retail pharmacies. Comparable OTC ear-care brand targeting the same consumer segment with similar regulatory positioning under DSHEA.

TypeBroad incumbent
Description

Direct-to-consumer OTC hearing aid company (Eargo Neo). Addresses the same end consumer (adults with early/mild sensorineural hearing loss) but with amplification devices rather than a supplement; useful comparator on DTC channel economics in hearing health.

7Sound Pharmaceuticals
TypeEmerging player
Description

Clinical-stage developer of ebselen (SPI-1005) for noise-induced hearing loss and ototoxicity. Closely comparable to ACEMg's primary indications (noise-induced and aminoglycoside ototoxicity) on the pharmaceutical side.

TypeDirect peer
Description

A long-standing OTC supplement brand (Lipo-Flavonoid Plus) marketed specifically for tinnitus and ear health via retail pharmacy and DTC channels. Most directly comparable product competitor to ACEMg in the 'supplement for hearing/tinnitus' category.

TypeDirect peer
Description

Sells 'Arches Tinnitus Formula,' a branded natural-supplement product for tinnitus and hearing-support sold through DTC and practitioner channels. Closely comparable category, target user, and channel overlap with Soundbites.

TypeEmerging player
Description

Clinical-stage biotech developing therapeutics to protect, repair, and restore hearing—most directly comparable to the pharma-path indication set Soundbites may pursue (ototoxic protection, genetic hearing loss). Provides a reference point for the prescription drug upside Soundbites could pursue.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Soundbites

Hearing Health Dietary Supplementssoundbites.com

Soundbites Public Benefit Corporation sells a patented ACEMg dietary supplement for hearing preservation, serving adults with sensorineural hearing loss and noise-exposed individuals through direct-to-consumer e-commerce and clinician wholesale channels, complemented by the Soundware assessment platform and Otis AI chatbot.

What Soundbites does

Soundbites Public Benefit Corporation is a Delaware-incorporated hearing health company that commercializes a patented micronutrient formulation called ACEMg (provitamin A/beta-carotene, vitamins C and E, and magnesium) as a once-daily dietary supplement marketed under the Soundbites brand. The product targets adults with sensorineural hearing loss who fall in the clinical gap between diagnosis and hearing-aid candidacy, as well as individuals seeking protection from noise-induced or age-related hearing decline. The core offering is sold direct-to-consumer through shop.soundbites.com at $39.99 per 4-week supply (one-time) or $33.99 on a cancellable 4-week subscription, with a 12-week starter kit priced at $80. A parallel wholesale channel serves licensed audiologists, primary care physicians, and otolaryngologists for in-office dispensing.

The technology base is anchored by 11 issued U.S. patents (two held directly by Soundbites PBC and nine exclusively licensed from the University of Michigan Kresge Hearing Research Institute) and 26 peer-reviewed publications documenting the formulation's mechanism of action in reducing cochlear oxidative stress. Manufacturing uses RP Scherer softgel technology in an FDA-certified pharmaceutical facility. Two adjacent software products extend the portfolio: Soundware, a validated at-home speech-in-noise and tone hearing assessment platform for longitudinal self-monitoring, and Otis, an RAG-based generative AI chatbot that fields consumer questions about hearing health. The company ships to the United States (free shipping), Canada, Hong Kong, the United Kingdom, the Netherlands, and China.

Soundbites operates as a Public Benefit Corporation with 1-10 employees, headquartered at 2370 East Stadium Blvd, Ann Arbor, Michigan, with a secondary office in Windsor, Canada. The company was incorporated in 2017 by Barry Seifer (CEO) following the passing of co-founder Dr. Josef M. Miller, the University of Michigan auditory neuroscientist whose 38-year research program generated the ACEMg technology and underlying patents. Capital formation has come from academic and governmental grants — approximately $22 million in NIH/NIDCD funding (1988-2017) and a €5 million European Commission medical innovation grant (2012) — rather than venture capital. Distribution combines a consumer e-commerce front end with a clinician wholesale tier and content marketing through the company Journal, press relations, and clinician education resources.

Soundbites firmographics

Firmographics
Name
Soundbites
Legal name
Soundbites Public Benefit Corporation
Website
https://soundbites.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Soundbites Public Benefit Corporation sells a patented ACEMg dietary supplement for hearing preservation, serving adults with sensorineural hearing loss and noise-exposed individuals through direct-to-consumer e-commerce and clinician wholesale channels, complemented by the Soundware assessment platform and Otis AI chatbot.
Ownership category
akta.pro rank

Soundbites industry classification

Industry
Product category
Hearing Health Dietary Supplements
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYEDAFAKAC
Assistive Hearing & Communication Access (Captioning, Hearing Support, Transcription)
Education/Education Technology (EdTech) & Digital Learning/Accessibility, Assistive Technology & Special Needs EdTech

Keywords

  • Hearing preservation supplements
  • Auditory micronutrition
  • Noise-induced hearing loss
  • Cochlear oxidative stress
  • Sensorineural hearing support

Where Soundbites is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Offices2 records

Markets served

Soundbites business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Direct Product Sales: Sale of ACEMg supplement (Soundbites) directly to consumers via e-commerce platform. One-time purchases and subscription plans for individual consumers seeking hearing preservation supplements.
  2. Wholesale/Professional Sales: Wholesale pricing offered to licensed healthcare practitioners (audiologists, physicians) for in-office dispensing. Includes volume pricing and access to clinical support resources.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goOne-time purchase - $39.99 per bottle
SubscriptionMonthlySubscription - $33.99 per 4-week cycle
SubscriptionPay-as-you-go12-Week Starter Kit - $80 (save $40)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Soundbites product offering

Product offering

Core offering

Soundbites sells a patented daily dietary supplement (ACEMg softgel) that delivers a specific combination of provitamin A/beta-carotene, vitamin C, vitamin E, and magnesium in patented ratios to support inner ear antioxidant defenses and preserve auditory function. The supplement is offered directly to consumers via the company's e-commerce store as one-time purchases or 4-week subscriptions, and through wholesale clinician channels for in-office dispensing by audiologists and physicians. The company also operates Soundware (a free at-home hearing assessment platform) and Otis (an AI chatbot) to support product adoption and hearing health education.

Product overview

Soundbites Public Benefit Corporation (PBC) offers a portfolio of hearing health products built around the patented ACEMg (Antioxidant vitamins C and E, and Magnesium) formulation. The core offering is the Soundbites dietary supplement (softgel capsules), which is paired with Soundware — a free at-home hearing assessment platform (speech-in-noise and tone tests) — enabling users to monitor and measure the supplement's impact on their hearing. An AI chatbot called Otis, powered by RAG and generative models, provides hearing health information to website visitors. The portfolio is grounded in 38 years of peer-reviewed research from the University of Michigan Kresge Hearing Research Institute.

Differentiator

Problem solved

Functional benefit

Brands

  • Otis: AI-powered hearing health chatbot (otology information system) designed to answer hearing questions and provide information about Soundbites and hearing preservation
  • OTIS Study

Products and services

  • Soundbites (ACEMg) Daily Hearing Preservation Supplement A daily dietary supplement in softgel capsule form containing the patented ACEMg formula (provitamin A/beta-carotene, vitamin C, vitamin E, and magnesium). Manufactured in an FDA-certified pharmaceutical facility using RP Scherer softgel technology. Sold to adults with diagnosed sensorineural hearing loss or seeking hearing preservation, and dispensed in-office by licensed clinicians.
  • Soundware Hearing Assessment Platform

Quantifiable outcome

  • 75.3% of daily ACEMg users maintained or improved DPOAE scores over two years, compared to 26.8% in untreated controls
  • +3 more outcomes

Companies that use Soundbites

Customer profile

Segments5 records

Ideal customer profiles3 records

Soundbites technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Soundbites partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, significant, supporting and active.

  • University of Michigan - Kresge Hearing Research InstitutecoreStrategic or Co-development Partner38-year research partnership with Dr. Josef M. Miller at the University of Michigan Medical School Kresge Hearing Research Institute. This partnership developed the foundational ACEMg technology, including 9 patents exclusively licensed to Soundbites PBC. Research supported by NIH/NIDCD grants totaling approximately $22 million over 29 years.
  • Keep Hearing InitiativecoreStrategic or Co-development PartnerAffiliated 501(c)(3) nonprofit organization that supports research, education, and global access to hearing preservation. Contributed to Soundbites PBC's research and education projects since 2019, producing educational videos, co-authoring the real-world evidence study, and collaborating on Soundware development. Pursues global access to ACEMg independent of ability to pay.
  • Lake Forest Hearing ProfessionalssignificantStrategic or Co-development PartnerPrivate audiology clinic in Lake Forest, Illinois that served as the clinical site for the real-world evidence study. Records were extracted from the clinic's electronic medical records and deidentified by licensed audiologist L.A. Halvorson before analysis.
  • ProHearing ConsortiumsignificantStrategic or Co-development PartnerEuropean Commission-funded consortium of three universities and Hearing Health Science, Inc. (University of Michigan patent licensee) for translational research on ACEMg from 2012-2020.
  • Soundware LabssupportingTechnology or IntegrationR&D partner contributing to Soundware hearing assessment platform development.
  • Soundhub DenmarksupportingTechnology or IntegrationR&D partner listed on website footer alongside other research partners.
  • OTIS Study (Clinical Trial NCT06477354)activeStrategic or Co-development PartnerClinical study titled 'ACEMg for Hearing Preservation and Tinnitus Relief' registered at clinicaltrials.gov (NCT06477354) evaluating ACEMg's impact on hearing preservation and tinnitus outcomes using AirPods hearing test data from participants.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Soundbites competitors and assessment

Company assessment

Broad incumbents

  • Audicus: Online hearing-aid retailer serving adults with mild-to-moderate hearing loss via subscription/financing models. Comparable DTC hearing-health customer and GTM motion, but in amplification rather than supplements.
  • Care/of: Personalized DTC vitamin/supplement brand with subscription model, transparent quality sourcing, and direct e-commerce — analogous business model and DTC mechanics for a subscription-driven health product like ACEMg.
  • Thorne: Premium, science-led DTC supplement brand with practitioner-channel distribution and NSF/clinical quality positioning. Highly comparable business model, brand posture, and clinician channel strategy to Soundbites' ACEMg offering.
  • Eargo: Direct-to-consumer OTC hearing aid company (Eargo Neo). Addresses the same end consumer (adults with early/mild sensorineural hearing loss) but with amplification devices rather than a supplement; useful comparator on DTC channel economics in hearing health.

Emerging players

  • Frequency Therapeutics: Clinical-stage company developing regenerative therapies for hearing loss (e.g., FX-322). Direct strategic reference for the drug-development trajectory that Soundbites could ultimately pursue if human trials and IP mature.
  • Sound Pharmaceuticals: Clinical-stage developer of ebselen (SPI-1005) for noise-induced hearing loss and ototoxicity. Closely comparable to ACEMg's primary indications (noise-induced and aminoglycoside ototoxicity) on the pharmaceutical side.
  • Decibel Therapeutics (now part of Regeneron): Clinical-stage biotech developing therapeutics to protect, repair, and restore hearing—most directly comparable to the pharma-path indication set Soundbites may pursue (ototoxic protection, genetic hearing loss). Provides a reference point for the prescription drug upside Soundbites could pursue.

Direct peers

  • Similasan: Swiss-based OTC brand selling homeopathic ear-care products (e.g., Ear Relief Drops) through retail pharmacies. Comparable OTC ear-care brand targeting the same consumer segment with similar regulatory positioning under DSHEA.
  • Lipo-Flavonoid: A long-standing OTC supplement brand (Lipo-Flavonoid Plus) marketed specifically for tinnitus and ear health via retail pharmacy and DTC channels. Most directly comparable product competitor to ACEMg in the 'supplement for hearing/tinnitus' category.
  • Arches Natural Products: Sells 'Arches Tinnitus Formula,' a branded natural-supplement product for tinnitus and hearing-support sold through DTC and practitioner channels. Closely comparable category, target user, and channel overlap with Soundbites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Soundbites social profiles

Digital presence

Soundbites financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Soundbites leadership team

Management profile

Number of profiles

Profiles2 records

Soundbites funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Soundbites M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Soundbites

What does Soundbites do?

Soundbites sells a patented daily dietary supplement (ACEMg softgel) that delivers a specific combination of provitamin A/beta-carotene, vitamin C, vitamin E, and magnesium in patented ratios to support inner ear antioxidant defenses and preserve auditory function. The supplement is offered directly to consumers via the company's e-commerce store as one-time purchases or 4-week subscriptions, and through wholesale clinician channels for in-office dispensing by audiologists and physicians. The company also operates Soundware (a free at-home hearing assessment platform) and Otis (an AI chatbot) to support product adoption and hearing health education.

Is Soundbites a public or private company?

Soundbites is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Soundbites founded?

Soundbites was founded in 2017. It employs 1 to 10 people.

Where is Soundbites based?

Soundbites is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does Soundbites make money?

Two revenue lines are on record. Direct Product Sales are the primary driver. The others are wholesale/Professional Sales.

Who are Soundbites's main competitors?

Broad incumbents on record are Audicus, Care/of, Thorne and Eargo. Emerging players are Frequency Therapeutics, Sound Pharmaceuticals and Decibel Therapeutics (now part of Regeneron). Direct peers are Similasan, Lipo-Flavonoid and Arches Natural Products.

Does Soundbites have an API?

No public API is recorded for Soundbites.

What industry is Soundbites in?

Soundbites's product category is Hearing Health Dietary Supplements. Its primary akta.pro industry code is HLAIADAF, Eye, Ear & Nasal Care, with a secondary code of EDAFAKAC, Assistive Hearing & Communication Access (Captioning, Hearing Support, Transcription). Its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceFirst Published Real-World Evidence Study Shows Hearing Preservation Supplement Maintained or Improved Auditory Function in 75.3% of Daily UsersA two-year real-world study of ACEMg, a patented antioxidant supplement, found 75.3% of daily users maintained or improved objective cochlear function, versus 26.8% in an untreated control group. The study, published in Global Advances in Integrative Medicine and Health, used distortion-product otoacoustic emission testing and is indexed on PubMed Central.PrwebSoundbites Announces U.S. Patent to Restore Hearing SensitivitySoundbites, a public benefit corporation dedicated to hearing preservation, has been granted a new U.S. patent by the USPTO covering methods to restore hearing sensitivity by targeting the myelin of the auditory nerve. The patent builds on decades of research by Dr. Josef Miller at the University of Michigan Medical School and expands the application of Soundbites' ACEMg® auditory neuroscience technology beyond hearing preservation to include nerve structure restoration. This development targets the common problem of hearing difficulty in noisy environments such as restaurants.BioSpaceSoundbites Announces U.S. Patent to Restore Hearing SensitivitySoundbites, a public benefit corporation focused on hearing preservation, announced that the USPTO has issued the company a new patent covering methods to restore hearing sensitivity by targeting the myelin of the auditory nerve. The patent builds on decades of research by Dr. Josef Miller at the University of Michigan Medical School and expands the scope of Soundbites' ACEMg® technology beyond hearing preservation to include restoration of nerve structures critical for sound processing in noisy environments. The company is currently conducting the IRB-approved OTIS Study to evaluate the clinical effectiveness of ACEMg on tinnitus and hyperacusis in adults.